BiotechTube
Home/Advent Therapeutics/Craig Gelfand, PhD
CG

Craig Gelfand, PhD

Head of R&D

Advent Therapeutics

Therapeutic Areas

NeonatologyRare DiseasesPulmonology

Advent Therapeutics Pipeline

DrugIndicationPhase
Vitamin A Palmitate (IM)Bronchopulmonary Dysplasia (BPD)Unknown
Vitamin A Palmitate (Aerosolized)Bronchopulmonary Dysplasia (BPD)Unknown
Vitamin A Palmitate PlatformRetinopathy of Prematurity (ROP)Unknown

Leadership Team at Advent Therapeutics

DL
David L. Lopez, Esq., CPA
CEO and co-founder
RS
Robert Segal, MD, FACP
CMO and co-founder
JM
Jan Mazela, MD, PhD
Chief Medical Advisor and co-founder
View full Advent Therapeutics profile